In this study, we firstly confirmed that ID4 was highly expressed in the TNBC and Her-2 overexpression breast cancers, and its expression was negative correlated with ER and PR, which was consistent with Best and Garraway's reports. The gene discussed is PGR; the disease is breast carcinoma.